Trial Details

RECRUITING
Basic Information
Clinical ID c107
Identifier NCT07168434
Trial Title Saccharomyces Boulardii CNCM I-745 in Irritable Bowel Syndrome
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions IBS (Irritable Bowel Syndrome)|IBS-D (Diarrhea-predominant)|IBS, Mixed Symptoms
Interventions DRUG: Saccharomyces Boulardii 250 MG|DRUG: Placebo 250 mg
Participant Information
Sponsor Biocodex
City Braga
Country/Region Portugal
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2025-10-22
Primary Completion Date 2026-10-11
Completion Date 2026-10-11